Steven Shoelson

Professor of Medicine , Joslin Diabetes Center 

Location: United States

Consulting Services


Areas Of Interest

Salicylates Phosphoproteins Inflammation Insulin Resistance Receptor, Insulin

Professional Narrative

​Dr. Shoelson’s interests include developing new treatment strategies based on underlying pathophysiology and the pathophysiology of insulin resistance and diabetes. His laboratory identifies physiological and pathological mechanisms in metabolism with the potential for development of new therapeutics. Through a series of basic and clinical studies (TINSAL-T2D) his showed that salicylate, the world’s oldest anti-inflammatory drug, lowers blood sugar and lipids in patients with diabetes.


Employment


Education


Referees


Publications


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :